Nursing Elites

1. A client with a serum albumin level of 3 g/dL has a pressure ulcer. What should the nurse do first?

• A. Monitor the client's fluid and electrolyte balance
• B. Consult a dietitian to improve the client's nutritional status
• C. Administer a protein supplement
• D. Administer an anti-inflammatory medication

Correct answer: B

Rationale: The correct first action for a client with a serum albumin level of 3 g/dL and a pressure ulcer is to consult a dietitian to improve the client's nutritional status. Adequate nutrition is essential for wound healing. Monitoring fluid and electrolyte balance is important but not the first priority in this situation. Administering a protein supplement can be considered after dietary evaluation. Administering an anti-inflammatory medication is not the primary intervention for addressing a pressure ulcer related to low albumin levels.

2. What is an early sign indicating the need for suctioning a client's tracheostomy?

• A. Irritability
• B. Hypotension
• C. Flushing
• D. Bradycardia

Correct answer: A

Rationale: Irritability is a crucial early sign that a client with a tracheostomy may require suctioning. Irritability could indicate a lack of oxygenation due to the airway blockage, prompting the need for suctioning to clear the airway. Hypotension, flushing, and bradycardia are not typically direct indicators for suctioning a tracheostomy. Hypotension may suggest hemodynamic instability, flushing could be related to autonomic responses, and bradycardia might indicate a cardiac issue rather than the need for suctioning.

3. When should a healthcare provider suction a client's tracheostomy?

• A. When the client is hypotensive
• B. When the client is irritable
• C. When the client is flushed
• D. When the client is bradycardic

Correct answer: B

Rationale: Irritability is an early sign that suctioning is required to clear secretions in a client with a tracheostomy. Hypotension, flushing, and bradycardia are not direct indicators for suctioning a tracheostomy. Hypotension may indicate a need for fluid resuscitation or other interventions, flushing could be due to various reasons like fever, and bradycardia may require evaluation for cardiac causes.

4. A client receiving chemotherapy is experiencing fatigue. Which intervention should the nurse implement to manage the client's fatigue?

• A. Encourage the client to take short naps during the day
• B. Instruct the client to remain on bedrest
• C. Provide the client with a high-calorie diet
• D. Encourage the client to increase activity levels

Correct answer: A

Rationale: The correct intervention to manage fatigue in a client receiving chemotherapy is to encourage the client to take short naps during the day. Fatigue is a common side effect of chemotherapy, and allowing the client to rest can help combat this symptom. Instructing the client to remain on bedrest (Choice B) is not recommended as it may lead to deconditioning and worsen fatigue. Providing a high-calorie diet (Choice C) may be beneficial for overall nutrition but does not directly address fatigue. Encouraging the client to increase activity levels (Choice D) may exacerbate fatigue instead of alleviating it.

5. A nurse is reviewing the laboratory results of a client who is undergoing screening for prostate cancer. The nurse should expect an elevation in which of the following laboratory values?

• A. Prostate-specific antigen (PSA)
• B. Human chorionic gonadotropin (hCG)
• C. Alpha-fetoprotein (AFP)
• D. Carcinoembryonic antigen (CEA)

Correct answer: A

Rationale: The correct answer is A: Prostate-specific antigen (PSA). PSA is a marker specifically used for prostate cancer screening. Elevated levels of PSA can indicate prostate cancer or other prostate-related issues, prompting the need for further diagnostic investigations. Choices B, C, and D are not typically associated with prostate cancer screening. Human chorionic gonadotropin (hCG) is related to pregnancy, alpha-fetoprotein (AFP) is associated with liver and germ cell tumors, and carcinoembryonic antigen (CEA) is linked to colorectal cancer.

Similar Questions